GRAL · GRAIL, Inc. · Metrics
$124.14
+1.72 (+1.40%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$5.47B
Shares
44.67M
Volume · Oct 20
129.4K
Avg daily vol (3M)
986.6K
GRAL metrics
68 of 116 screener metrics currently available.
Market overview
2 metricsShare price
$122.42
Market cap
$5.47B
Price action
20 metricsPrice change (1W)
-10.9%
Price change (30D)
+13.4%
Price change (3M)
+77.7%
Price change (6M)
+139.1%
Price change (YTD)
+43.0%
Price change (1Y)
+56.9%
Trailing year
Price change (5Y)
—
52-week high
$154.08
52-week low
$43.03
Change from 52-week high
-20.5%
Change from 52-week low
+184.5%
Annualized volatility
102.1%
Annualized volatility (3M)
106.1%
Beta
2.8
RSI (14D)
51.5
Price vs SMA 50
+23.9%
Price vs SMA 200
+60.8%
Avg volume (3M)
986,601
Relative volume
0.6
Average dollar volume
$97.59M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
44.67M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
31.5×
reciprocal yield 3.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
31.8×
reciprocal yield 3.1%
P / book
2.1
reciprocal yield 48.3%
FCF yield
-5.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
13.7×
reciprocal yield 7.3%
EV / revenue historical average (5Y)
13.7×
reciprocal yield 7.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
—
Operating margin
-338.4%
Trailing 12 months
Net margin
-236.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$559.25M
Net income (TTM)
−$391.59M
Trailing 12 months
Diluted EPS (TTM)
$-9.68
FCF margin
-179.2%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+25.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$165.26M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+20.4%
Year over year · more shares
Revenue CAGR (3Y)
+38.4%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-15.4%
Return on assets
-13.8%
Debt / equity
0.0
Current ratio
10.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$296.16M
Quick ratio
10.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$55.65M
Latest balance sheet
Cash & equivalents
$55.65M
Total assets
$2.84B
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$294.75M
Capital expenditures (TTM)
$1.41M
R&D (TTM)
$190.99M
SG&A (TTM)
—
Stock compensation (TTM)
$64.25M
R&D / revenue
115.6%
Stock compensation / revenue
38.9%
Ownership (13F)
3 metrics13F filers
380
13F filer change QoQ
+9
Institutional ownership
89.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
15.3%
Short interest
3 metricsShort interest
17.9%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
69 / 100
Insider activity
2 metricsNet insider buying (90D)
−$12.10M
Insider-sentiment score
20 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1699031
CUSIP
384747101
13F (30d)
52 filings
52 filers
Visit website
Investor relations